Volume 16, Issue 36 (Winter 2004)
IJN 2004, 16(36): 47-52 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
M. Farajollahi, M. Alikhani, F. Farmani, F. Hosseini. FATIGUE IN CANCER PATIENTS RECEIVING CHEMOTHERAPY. IJN 2004; 16 (36) :47-52
URL: http://ijn.iums.ac.ir/article-1-69-en.html
URL: http://ijn.iums.ac.ir/article-1-69-en.html
Abstract: (14764 Views)
Fatigue is one of the most common and a distressing side effect of cancer and its treatments. It can affect all aspects of patients’ life and leads to several other hardships.
To determine fatigue intensity and it’s changing pattern among those suffering from cancer receiving chemotherapy, a descriptive longitudinal study was conducted. The principal method of data collection was a daily diary, with 28 visual analogue scales (Rhoten Fatique scale). Contributors were 120 cancer patients, receiving chemotherapy.
The results indicated that all patients experienced fatigue during their chemotherapy cycles. The pattern of fatigue intensity showed alteration in fatigue scores through a chemotherapy cycle with apparent peak on the fifth day of the cycle. There was a significant relationship between the site of cancer and the level of recorded fatigue ( = 20/98, df=10, P=0/021).A meaningful relationship was identified between the number of chemotherapy cycles and the level of recorded fatigue ( =50/63, df=7, P<0/0001), but there was not a significant relationship between the chemotherapy regimens and the level of recorded fatigue ( = 12/65, df= 9, P= 0/179).
To conclude, Findings showed that chemotherapy was associated with fatigue, and different scores were related to the site of cancer and the number of chemotherapy cycles. Therefore, recommendation is made about assessment and management of fatigue in these patients.
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Copyright © The Author(s);
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
